BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Falagas ME, Tansarli GS, Rafailidis PI, Kapaskelis A, Vardakas KZ. Impact of antibiotic MIC on infection outcome in patients with susceptible Gram-negative bacteria: a systematic review and meta-analysis. Antimicrob Agents Chemother 2012;56:4214-22. [PMID: 22615292 DOI: 10.1128/AAC.00663-12] [Cited by in Crossref: 49] [Cited by in F6Publishing: 20] [Article Influence: 4.9] [Reference Citation Analysis]
Number Citing Articles
1 Bader JC, Lakota EA, Andes DR, Rubino CM, Ambrose PG, Bhavnani SM. Time for Precision: A World Without Susceptibility Breakpoints. Open Forum Infect Dis 2018;5:ofy282. [PMID: 30581880 DOI: 10.1093/ofid/ofy282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Tai C, Tang H, Lee C. Clinical Outcomes and Adverse Effects in Septic Patients with Impaired Renal Function Who Received Different Dosages of Cefoperazone–Sulbactam. Antibiotics 2022;11:460. [DOI: 10.3390/antibiotics11040460] [Reference Citation Analysis]
3 Huang HY, Wang CF, Lu PL, Tseng SP, Wang YL, Chen TC, Chang K, Tu HP, Lin SY. Clinical Impact of the Revised 2019 CLSI Levofloxacin Breakpoints in Patients with Enterobacterales Bacteremia. Antimicrob Agents Chemother 2021;65:e00074-21. [PMID: 33782006 DOI: 10.1128/AAC.00074-21] [Reference Citation Analysis]
4 Falagas ME, Vouloumanou EK, Samonis G, Vardakas KZ. Fosfomycin. Clin Microbiol Rev. 2016;29:321-347. [PMID: 26960938 DOI: 10.1128/cmr.00068-15] [Cited by in Crossref: 232] [Cited by in F6Publishing: 99] [Article Influence: 38.7] [Reference Citation Analysis]
5 Hsieh CC, Chen PL, Lee CH, Yang CY, Lee CC, Ko WC. Definitive Cefazolin Therapy for Stabilized Adults with Community-Onset Escherichia coli, Klebsiella Species, and Proteus mirabilis Bacteremia: MIC Matters. J Clin Med 2020;9:E157. [PMID: 31936020 DOI: 10.3390/jcm9010157] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Veses-Garcia M, Antypas H, Löffler S, Brauner A, Andersson-Svahn H, Richter-Dahlfors A. Rapid Phenotypic Antibiotic Susceptibility Testing of Uropathogens Using Optical Signal Analysis on the Nanowell Slide. Front Microbiol 2018;9:1530. [PMID: 30042754 DOI: 10.3389/fmicb.2018.01530] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
7 Al-Anazi KA, Al-Jasser AM. Infections Caused by Acinetobacter baumannii in Recipients of Hematopoietic Stem Cell Transplantation. Front Oncol 2014;4:186. [PMID: 25072028 DOI: 10.3389/fonc.2014.00186] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
8 Kurenbach B, Gibson PS, Hill AM, Bitzer AS, Silby MW, Godsoe W, Heinemann JA. Herbicide ingredients change Salmonella enterica sv. Typhimurium and Escherichia coli antibiotic responses. Microbiology (Reading) 2017;163:1791-801. [PMID: 29139345 DOI: 10.1099/mic.0.000573] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
9 Ding X, Yu H, Qiao S. Lasso Peptide Microcin J25 Effectively Enhances Gut Barrier Function and Modulates Inflammatory Response in an Enterotoxigenic Escherichia coli-Challenged Mouse Model. Int J Mol Sci 2020;21:E6500. [PMID: 32899529 DOI: 10.3390/ijms21186500] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Coates J, Park BR, Le D, Şimşek E, Chaudhry W, Kim M. Antibiotic-induced population fluctuations and stochastic clearance of bacteria. Elife 2018;7:e32976. [PMID: 29508699 DOI: 10.7554/eLife.32976] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 9.8] [Reference Citation Analysis]
11 Villegas MV, Lyon S. Gram-negative infections: evolving treatments with expanding options. Future Sci OA 2018;4:FSO339. [PMID: 30416747 DOI: 10.4155/fsoa-2018-0071] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Kowalska-Krochmal B, Dudek-Wicher R. The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens 2021;10:165. [PMID: 33557078 DOI: 10.3390/pathogens10020165] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
13 Tadesse G, Tessema TS, Beyene G, Aseffa A. Molecular epidemiology of fluoroquinolone resistant Salmonella in Africa: A systematic review and meta-analysis. PLoS One 2018;13:e0192575. [PMID: 29432492 DOI: 10.1371/journal.pone.0192575] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
14 Newby BD. Development of Gentamicin Resistance During Treatment of Escherichia coli Ventilator-Associated Pneumonia in a Neonate. J Pharm Pract 2021;34:975-9. [PMID: 32648511 DOI: 10.1177/0897190020940124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Su TY, Ye JJ, Yang CC, Huang CT, Chia JH, Lee MH. Influence of borderline cefepime MIC on the outcome of cefepime-susceptible Pseudomonas aeruginosa bacteremia treated with a maximal cefepime dose: a hospital-based retrospective study. Ann Clin Microbiol Antimicrob 2017;16:52. [PMID: 28738848 DOI: 10.1186/s12941-017-0227-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
16 Imamovic L, Ellabaan MMH, Dantas Machado AM, Citterio L, Wulff T, Molin S, Krogh Johansen H, Sommer MOA. Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections. Cell 2018;172:121-134.e14. [PMID: 29307490 DOI: 10.1016/j.cell.2017.12.012] [Cited by in Crossref: 73] [Cited by in F6Publishing: 51] [Article Influence: 18.3] [Reference Citation Analysis]
17 Yu H, Li N, Zeng X, Liu L, Wang Y, Wang G, Cai S, Huang S, Ding X, Song Q, Qiao S. A Comprehensive Antimicrobial Activity Evaluation of the Recombinant Microcin J25 Against the Foodborne Pathogens Salmonella and E. coli O157:H7 by Using a Matrix of Conditions. Front Microbiol 2019;10:1954. [PMID: 31507565 DOI: 10.3389/fmicb.2019.01954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
18 Fernández OL, Diaz-Toro Y, Ovalle C, Valderrama L, Muvdi S, Rodríguez I, Gomez MA, Saravia NG. Miltefosine and antimonial drug susceptibility of Leishmania Viannia species and populations in regions of high transmission in Colombia. PLoS Negl Trop Dis 2014;8:e2871. [PMID: 24853871 DOI: 10.1371/journal.pntd.0002871] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 4.8] [Reference Citation Analysis]
19 Pancholi P, Carroll KC, Buchan BW, Chan RC, Dhiman N, Ford B, Granato PA, Harrington AT, Hernandez DR, Humphries RM, Jindra MR, Ledeboer NA, Miller SA, Mochon AB, Morgan MA, Patel R, Schreckenberger PC, Stamper PD, Simner PJ, Tucci NE, Zimmerman C, Wolk DM. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis. J Clin Microbiol 2018;56:e01329-17. [PMID: 29305546 DOI: 10.1128/JCM.01329-17] [Cited by in Crossref: 84] [Cited by in F6Publishing: 37] [Article Influence: 21.0] [Reference Citation Analysis]
20 O’donnell JN, Miglis CM, Lee JY, Tuvell M, Lertharakul T, Scheetz MH. Carbapenem susceptibility breakpoints, clinical implications with the moving target. Expert Review of Anti-infective Therapy 2016;14:389-401. [DOI: 10.1586/14787210.2016.1159131] [Cited by in Crossref: 5] [Article Influence: 0.8] [Reference Citation Analysis]
21 Tarumoto N, Kinjo Y, Kitano N, Sasai D, Ueno K, Okawara A, Izawa Y, Shinozaki M, Watarai H, Taniguchi M, Takeyama H, Maesaki S, Shibuya K, Miyazaki Y. Exacerbation of invasive Candida albicans infection by commensal bacteria or a glycolipid through IFN-γ produced in part by iNKT cells. J Infect Dis 2014;209:799-810. [PMID: 24096333 DOI: 10.1093/infdis/jit534] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
22 Teimouri H, Kolomeisky AB. Theoretical investigation of stochastic clearance of bacteria: first-passage analysis. J R Soc Interface 2019;16:20180765. [PMID: 30890051 DOI: 10.1098/rsif.2018.0765] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
23 McWilliams CS, Condon S, Schwartz RM, Ginocchio CC. Incidence of extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates that test susceptible to cephalosporins and aztreonam by the revised CLSI breakpoints. J Clin Microbiol 2014;52:2653-5. [PMID: 24789185 DOI: 10.1128/JCM.03613-13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]